Stay updated on Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T22:00:40.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The Publications section now states that PubMed-listed publications are automatically filled and may not all pertain to the study. A revision tag (Revision: v3.3.2) was added.
    Difference
    0.1%
    Check dated 2025-11-25T11:25:17.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Deleted: a government funding/operating status notice; this does not affect the trial content, eligibility criteria, or how users interact with the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page. The content remains focused on the Nivolumab and AVD trial details, eligibility criteria, and outcomes.
    Difference
    0.5%
    Check dated 2025-11-03T20:57:30.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Core content updated to reflect funding-related operating status and a new version release (v3.2.0), replacing the previous v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T05:30:19.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:03:42.000Z thumbnail image

Stay in the know with updates to Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.